Peel Hunt Upgrades Dr. Martens (LON:DOCS) to Buy

Key Points

Error: Response status code does not indicate success: 429 (Too Many Requests).

Dr. Martens (LON:DOCS - Get Free Report) was upgraded by investment analysts at Peel Hunt to a "buy" rating in a note issued to investors on Monday, August 18th, Marketbeat.com reports.

A number of other equities research analysts have also recently weighed in on the stock. Royal Bank Of Canada dropped their price target on shares of Dr. Martens from GBX 7,000 to GBX 6,000 and set a "sector perform" rating for the company in a research report on Monday, May 19th. Deutsche Bank Aktiengesellschaft reiterated a "hold" rating on shares of Dr. Martens in a research report on Friday, July 11th. One research analyst has rated the stock with a Buy rating and two have given a Hold rating to the company's stock. According to MarketBeat, the company currently has a consensus rating of "Hold" and a consensus price target of GBX 6,000.

Dr. Martens Price Performance

Shares of DOCS opened at GBX 90.75 on Monday. Dr. Martens has a 1-year low of GBX 43.02 and a 1-year high of GBX 94.35. The stock has a market cap of £876.26 million, a PE ratio of 18,150.00, a P/E/G ratio of 6.40 and a beta of 0.11. The firm has a 50-day simple moving average of GBX 81.03 and a two-hundred day simple moving average of GBX 66.85. The company has a debt-to-equity ratio of 127.27, a current ratio of 2.85 and a quick ratio of 1.13.

Dr. Martens (LON:DOCS - Get Free Report) last announced its quarterly earnings results on Thursday, June 5th. The company reported GBX 2.40 earnings per share for the quarter. Dr. Martens had a net margin of 7.89% and a return on equity of 18.91%. As a group, analysts forecast that Dr. Martens will post 2.5809394 EPS for the current year.

Insider Buying and Selling at Dr. Martens

In other Dr. Martens news, insider Giles Wilson acquired 105,838 shares of the company's stock in a transaction that occurred on Monday, September 1st. The stock was purchased at an average price of GBX 91 per share, for a total transaction of £96,312.58. Insiders have purchased a total of 137,011 shares of company stock valued at $12,452,601 in the last ninety days. Insiders own 2.76% of the company's stock.

About Dr. Martens

Founded in 1960, Dr. Martens is an iconic British brand with a global presence. “Docs” or “DMs” were originally produced for their durability for workers, before being adopted by diverse youth subcultures and associated musical movements. Today, Dr. Martens has transcended its roots while still celebrating its proud history.